Piramal Pharma Ltd

Integrated Filing — Corporate Governance (NSE XBRL)

Company Home Dashboard NSE Viewer

Filing Summary

Company
Piramal Pharma Limited
Symbol
PPLPHARMA
Quarter Ended
31-Mar-2026
Submission
New

General Disclosures

Advertisements As Per Regulation471
Yes
Annual Return As Provided Under Section92Of The Companies Act2013
Yes
Approval For Material Related Party Transactions
Not Applicable
Approval Of The Board And Shareholders For Compensation Or Profit Sharing
Not Applicable
Audio Or Video Recordings And Transcripts Of Post Earinings Or Quarterly Calls
Yes
Board Composition
Yes
Code Of Conduct
Yes
Compliance Certificate
Yes
Compliance With Sub Regulation3Of Regulation46With Respect To Accuracy Of Disclosures On The Website And Timely Updation
Yes
Confirmation That The Disclosures Are In A Separate Section As Specified In Sub Regulation2Of Regulation46
Yes
Credit Rating Or Revision In Credit Rating Obtained
Yes
Date Of End Of Financial Year
31-Mar-2026
Date Of End Of Reporting Period
31-Mar-2026
Date Of Signing
29-Apr-2026
Date Of Start Of Financial Year
01-Apr-2025
Designation Of Person
Chief Financial Officer
Designation Of Person Affirmations
Chief Financial Officer
Designation Of Person For Annual Affirmations
Chief Financial Officer
Designation Of Person For Quartely Affirmations
Chief Financial Officer
Details Of Agreements Entered Into With The Media Companies And Or Their Associates
Not Applicable
Details Of Business
Yes
Details Of Establishment Of Vigil Mechanism Or Whistle Blower Policy
Yes
Disclosure Of Contact Details Of KMP Who Are Authorized For The Purpose Of Determining Materiality Under Sub Regulation5Of Regulation30
Yes
Disclosure Of Related Party Transactions On Consolidated Basis
Yes
Disclosure Web Link Of Annual Return As Provided Under Section92Of The Companies Act2013Is Placed
https://www.piramalpharma.com/financial-reports
Disclosure Web Link Of Audio Or Video Recordings And Transcripts Of Post Earinings Or Quarterly Calls Is Placed
https://www.piramalpharma.com/financial-reports
Disclosure Web Link Of Company At Advertisements As Per Regulation471Is Placed
https://www.piramalpharma.com/corporate-governance
Disclosure Web Link Of Company At Dividend Distribution Policy As Per Regulation43A1Is Placed
https://www.piramalpharma.com/corporate-governance
Disclosure Web Link Of Company At Materiality Policy As Per Sub Regulation4Regulation30Is Placed
https://www.piramalpharma.com/corporate-governance
Disclosure Web Link Of Company At Separate Audited Financial Statements Of Each Subsidiary Of The Listed Entity Is Placed
https://www.piramalpharma.com/financial-reports
Disclosure Web Link Of Company At Which Credit Rating Or Revision In Credit Rating Obtained Is Placed
https://www.piramalpharma.com/shareholder-information
Disclosure Web Link Of Company At Which Details Of Business Is Placed
https://www.piramalpharma.com/
Disclosure Web Link Of Company At Which Details Of Establishment Of Vigil Mechanism Or Whistle Blower Policy Is Placed
https://www.piramalpharma.com/corporate-governance
Disclosure Web Link Of Company At Which Financial Results Is Placed
https://www.piramalpharma.com/financial-reports
Disclosure Web Link Of Company At Which Policy For Determining Material Subsidiaries Is Placed
https://www.piramalpharma.com/corporate-governance
Disclosure Web Link Of Company At Which Policy On Dealing With Related Party Transactions Is Placed
https://www.piramalpharma.com/corporate-governance
Disclosure Web Link Of Company At Which Shareholding Pattern Is Placed
https://www.piramalpharma.com/shareholder-information
Disclosure Web Link Of Compliance With Sub Regulation3Of Regulation46With Respect To Accuracy Of Disclosures On The Website And Timely Updation Is Placed
https://www.piramalpharma.com/
Disclosure Web Link Of Confirmation That The Disclosures Are In A Separate Section As Specified In Sub Regulation2Of Regulation46Is Placed
https://www.piramalpharma.com/disclosures-under-regulation-46-of-sebi-lodr
Disclosure Web Link Of Disclosure Of Contact Details Of KMP Who Are Authorized For The Purpose Of Determining Materiality Under Sub Regulation5Of Regulation30Is Placed
https://www.piramalpharma.com/investor-contacts
Disclosure Web Link Of Disclosures Under Sub Regulation8Of Regulation30Is Placed
https://www.piramalpharma.com/corporate-governance
Disclosure Web Link Of Employee Benefit Scheme Documents Framed In Terms Of SEBI Share Based Employee Benefits And Sweat Equity Regulations2021Is Placed
https://www.piramalpharma.com/corporate-governance
Disclosure Web Link Of Memorandum Of Association And Articles Of Association Is Placed
https://www.piramalpharma.com/corporate-governance
Disclosure Web Link Of Schedule Of Analyst Or Institutional Investor Meet And Presentation Prepared By Listed Entity For Analyst Or Institutional Investor Meet Is Placed
https://www.piramalpharma.com/financial-reports
Disclosure Web Link Of Secretarial Compliance Report Is Placed
https://www.piramalpharma.com/corporate-governance
Disclosures Under Sub Regulation8Of Regulation30
Yes
Dividend Distribution Policy As Per Regulation43A1
Yes
Employee Benefit Scheme Documents Framed In Terms Of SEBI Share Based Employee Benefits And Sweat Equity Regulations2021
Yes
Fees Or Compensation
Yes
Financial Results
Yes
Is SCORESID Available
Yes
ISIN
INE0DK501011
Market Capitalisation As Per Immediate Previous Financial Year
Top 500 listed entities
Materiality Policy As Per Sub Regulation4Regulation30
Yes
Memorandum Of Association And Articles Of Association
Yes
Minimum Information
Yes
MSEI Symbol
NOTLISTED
Name Of Signatory
Vivek Valsaraj
Name Of Signatory Affirmations
Vivek Valsaraj
Name Of Signatory For Annual Affirmations
Vivek Valsaraj
Name Of Signatory For Quartely Affirmations
Vivek Valsaraj
Name Of The Company
PIRAMAL PHARMA LIMITED
New Name And The Old Name Of The Listed Entity
Not Applicable
Other Corporate Governance Requirements With Respect To Subsidiary Of Listed Entity
Yes
Place
Mumbai
Plans For Orderly Succession For Appointments
Yes
Policy For Determining Material Subsidiaries
Yes
Policy For Related Party Transaction
Yes
Policy On Dealing With Related Party Transactions
Yes
Reason For Part F Of Annexure I Of The SEBI Circular Dated31December2024Related To Disclosure Of Loans Or Guarantees Or Comfort Letters Or Securities Etc Is Not Applicable To The Entity
No Loans/Gurantees/Comfort Letter/Securities are provided by listed entity during the period under review to - Promoter or any other entity controlled by them - Promoter Group or any other entity controlled by them - Directors (including relatives) or any other entity controlled by them - KMPs or any other entity controlled by them
Recommendation Of Board
Yes
Reporting Quarter
Yearly
Review Of Compliance Reports
Yes
Risk Assessment And Management
Yes
Schedule Of Analyst Or Institutional Investor Meet And Presentation Prepared By Listed Entity For Analyst Or Institutional Investor Meet
Yes
SCORES Registration ID
00877
Scrip Code
543635
Secretarial Compliance Report
Yes
Separate Audited Financial Statements Of Each Subsidiary Of The Listed Entity
Yes
Shareholding Pattern
Yes
Statements Of Deviations Or Variations As Specified In Regulation32
Not Applicable
Symbol
PPLPHARMA
The Listed Entity Has Approved Material Subsidiary Policy And The Corporate Governance Requirements With Respect To Subsidiary Of Listed Entity Have Been Complied
Yes
Type Of Company
Equity
Type Of Submission
Original
Vacancies In Respect Key Managerial Personnel
Not Applicable
Vigil Mechanism
Yes
Whether As Per Sub Regulation2ba Of Regulation27Of SEBILODR There Has Been Cyber Security Incidents During The Quarter
No
Whether Part A Of Annexure I Of The SEBI Circular Dated31December2024Related To Compliance Report On Corporate Governance Is Applicable To The Entity
Yes
Whether Part F Of Annexure I Of The SEBI Circular Dated31December2024Related To Disclosure Of Loans Or Guarantees Or Comfort Letters Or Securities Etc Is Applicable To The Entity
No

Additional Disclosures

Entry D_MeetingBOD1
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingBOD2
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit1
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit2
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit3
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit4
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit5
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit6
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit7
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit8
Whether Requirement Of Quorum Met
Yes
Official NSE disclosure viewer

If the viewer does not load, use the NSE Viewer button above to open it in a new tab.

Board Composition — Entity Disclosures

Disclosure Of Notes On Composition Of Board Of Directors Explanatory Text Block
Mr. S Ramadorai (DIN: 00000002) completed his term of 5 (five) consecutive years as Independent Director of the Company, on February 8, 2026 and ceased to be an Independent Director of the Company with effect from 9th February, 2026 and consequently, as Chairman/Member of the various Board Committees on which he served.
The Composition Of Board Of Directors Is In Terms Of Sebi Regulations2015
Yes
Chairperson Related to MD / CEO
No
Regular Chairperson
Yes

Composition of Board of Directors

SrTitleDirectorPANDINCategory 1Category 2Date of BirthDisqualifiedStatusSpecial ResolutionSpecial Resolution DateInitial AppointmentRe-appointmentCessationTenure (months)Listed DirectorshipsIndependent DirectorshipsAudit / Stakeholder MembershipsAudit / Stakeholder Chair Posts
1MsNandini Piramal******00286092Executive DirectorChairperson related to Promoter26-Oct-1980NoActiveNot Applicable04-Mar-202001-Apr-20241010
2MrPeter DeYoung******07152550Executive DirectorNot Applicable20-Apr-1978NoActiveNot Applicable04-Mar-202006-Oct-20231000
3MrVivek Valsaraj******06970246Executive DirectorNot Applicable12-Aug-1973NoActiveNot Applicable09-Feb-202209-Feb-20251010
4MrJairaj Purandare******00159886Non-Executive - Independent DirectorNot Applicable30-Jun-1959NoActiveNot Applicable09-Feb-202109-Feb-2026614474
5MrPeter Stevenson******09544706Non-Executive - Independent DirectorNot Applicable03-Feb-1953NoActiveNot Applicable30-Mar-202230-Mar-2022481100
6MrSridhar Gorthi******00035824Non-Executive - Independent DirectorNot Applicable31-Jul-1972NoActiveNot Applicable30-Mar-202230-Mar-2022483351
7MsVibha Paul Rishi******05180796Non-Executive - Independent DirectorNot Applicable19-Jun-1960NoActiveNot Applicable30-Aug-202230-Aug-2022434442
8MsNathalie Leitch******09557042Non-Executive - Non Independent DirectorNot Applicable29-Dec-1967NoActiveNot Applicable28-Jan-20251000
9MrAmit Jain******06917608Non-Executive - Non Independent DirectorNot Applicable04-May-1981NoActiveNot Applicable14-May-20251010
10MrAmit Soni******05111144Non-Executive - Independent DirectorNot Applicable28-Jan-1980NoActiveNot Applicable09-Feb-202611110
11MrS. Ramadorai******00000002Non-Executive - Independent DirectorNot Applicable06-Oct-1944NoActiveYes28-Jul-202209-Feb-202109-Feb-202109-Feb-2026600000

Committee Disclosures

Entry CompComit100
Date of Appointment
28-Jan-2026
Entry CompComit122
Date of Appointment
16-Apr-2021
Entry CompComit123
Date of Appointment
16-Apr-2021
Entry CompComit124
Date of Appointment
09-Feb-2022
Entry CompComit14
Date of Appointment
16-Apr-2021
Entry CompComit15
Date of Appointment
09-Feb-2026
Entry CompComit16
Date of Appointment
06-Jul-2022
Entry CompComit17
Date of Appointment
16-Apr-2021
Date Of Cessation Of Director In Committee
09-Feb-2026
Entry CompComit41
Date of Appointment
09-Feb-2026
Entry CompComit42
Date of Appointment
16-Apr-2021
Entry CompComit43
Date of Appointment
16-Apr-2021
Entry CompComit44
Date of Appointment
30-Aug-2022
Entry CompComit45
Date of Appointment
16-Apr-2021
Date Of Cessation Of Director In Committee
09-Feb-2026
Entry CompComit68
Date of Appointment
30-Aug-2022
Entry CompComit69
Date of Appointment
30-Aug-2022
Entry CompComit70
Date of Appointment
30-Aug-2022
Entry CompComit95
Date of Appointment
30-Aug-2022
Entry CompComit96
Date of Appointment
30-Aug-2022
Entry CompComit97
Date of Appointment
30-Aug-2022
Entry CompComit98
Date of Appointment
14-Oct-2022
Entry CompComit99
Date of Appointment
14-May-2025
Entry MainD
Composition And Role Of Risk Management Committee
Yes
Composition Of Audit Committee
Yes
Composition Of Nomination And Remuneration Committee
Yes
Composition Of Stakeholder Relationship Committee
Yes
Composition Of Various Committees Of Board Of Directors
Yes
Disclosure Web Link Of Company At Which Composition Of Various Committees Of Board Of Directors Is Placed
https://www.piramalpharma.com/corporate-governance
Memberships In Committees
Yes
Prior Or Omnibus Approval Of Audit Committee For All Related Party Transactions
Yes
Risk Management Committee
Yes
Role Of Audit Committee And Information To Be Reviewed By The Audit Committee
Yes
Role Of Nomination And Remuneration Committee
Yes
Role Of Stakeholders Relationship Committee
Yes
The Committee Members Have Been Made Aware Of Their Powers Role And Responsibilities As Specified In Sebi Regulations2015
Yes
The Composition Of Audit Committee Is In Terms Of Sebi Regulations2015
Yes
The Composition Of The Nomination And Remuneration Committee Is In Terms Of Sebi Regulations2015
Yes
The Composition Of The Risk Management Committee Is In Terms Of Sebi Regulations2015
Yes
The Composition Of The Stakeholders Relationship Committee Committee Is In Terms Of Sebi Regulations2015
Yes
Whether The Audit Committee Has A Regular Chairperson
Yes
Whether The Corporate Social Responsibility Committee Has A Regular Chairperson
Yes
Whether The Nomination And Remuneration Committee Has A Regular Chairperson
Yes
Whether The Risk Management Committee Has A Regular Chairperson
Yes
Whether The Stakeholders Relationship Committee Has A Regular Chairperson
Yes

Audit Committee

Additional Position
Chairperson
Director DIN
00159886
Member Name
Jairaj Purandare
Position
Non-Executive - Independent Director

Audit Committee

Additional Position
Member
Director DIN
05111144
Member Name
Amit Soni
Position
Non-Executive - Independent Director

Audit Committee

Additional Position
Member
Director DIN
00035824
Member Name
Sridhar Gorthi
Position
Non-Executive - Independent Director

Audit Committee

Additional Position
Member
Director DIN
00000002
Member Name
S. Ramadorai
Position
Non-Executive - Independent Director

Audit Committee

Audit Committee

Audit Committee

Corporate Social Responsibility Committee

Additional Position
Chairperson
Director DIN
00159886
Member Name
Jairaj Purandare
Position
Non-Executive - Independent Director

Corporate Social Responsibility Committee

Additional Position
Member
Director DIN
00286092
Member Name
Nandini Piramal
Position
Executive Director

Corporate Social Responsibility Committee

Additional Position
Member
Director DIN
06970246
Member Name
Vivek Valsaraj
Position
Executive Director

Corporate Social Responsibility Committee

Nomination and remuneration committee

Additional Position
Chairperson
Director DIN
00035824
Member Name
Sridhar Gorthi
Position
Non-Executive - Independent Director

Nomination and remuneration committee

Additional Position
Member
Director DIN
00159886
Member Name
Jairaj Purandare
Position
Non-Executive - Independent Director

Nomination and remuneration committee

Additional Position
Member
Director DIN
00286092
Member Name
Nandini Piramal
Position
Executive Director

Nomination and remuneration committee

Additional Position
Member
Director DIN
05180796
Member Name
Vibha Paul Rishi
Position
Non-Executive - Independent Director

Nomination and remuneration committee

Additional Position
Chairperson
Director DIN
00000002
Member Name
S. Ramadorai
Position
Non-Executive - Independent Director

Nomination and remuneration committee

Nomination and remuneration committee

Risk Management Committee

Additional Position
Member
Director DIN
09544706
Member Name
Peter Stevenson
Position
Non-Executive - Independent Director

Risk Management Committee

Additional Position
Chairperson
Director DIN
00286092
Member Name
Nandini Piramal
Position
Executive Director

Risk Management Committee

Additional Position
Member
Director DIN
00159886
Member Name
Jairaj Purandare
Position
Non-Executive - Independent Director

Risk Management Committee

Additional Position
Member
Director DIN
00035824
Member Name
Sridhar Gorthi
Position
Non-Executive - Independent Director

Risk Management Committee

Additional Position
Member
Director DIN
05180796
Member Name
Vibha Paul Rishi
Position
Non-Executive - Independent Director

Risk Management Committee

Additional Position
Member
Director DIN
06917608
Member Name
Amit Jain
Position
Non-Executive - Non Independent Director

Risk Management Committee

Risk Management Committee

Stakeholders Relationship Committee

Additional Position
Chairperson
Director DIN
05180796
Member Name
Vibha Paul Rishi
Position
Non-Executive - Independent Director

Stakeholders Relationship Committee

Additional Position
Member
Director DIN
00286092
Member Name
Nandini Piramal
Position
Executive Director

Stakeholders Relationship Committee

Additional Position
Member
Director DIN
06970246
Member Name
Vivek Valsaraj
Position
Executive Director
Entry MainD
Gap Between The Meetings Of The Risk Management Committee
Yes
Meeting Of Audit Committee
Yes
Meeting Of Board Of Directors
Yes
Meeting Of Independent Directors
Yes
Meeting Of Nomination And Remuneration Committee
Yes
Meeting Of Risk Management Committee
Yes
Meeting Of Stakeholders Relationship Committee
Yes
Quorum Of Board Meeting
Yes
Quorum Of Nomination And Remuneration Committee Meeting
Yes
Quorum Of Risk Management Committeemeeting
Yes
The Meetings Of The Board Of Directors And The Above Committees Have Been Conducted In The Manner As Specified In Sebi Regulations2015
Yes
Entry MeetingBOD1
Dates Of Meeting In The Previous Quarter
05-Nov-2025
Number Of Directors Present In Meeting Of Board Of Directors
10
Number Of Independent Directors Attending The Meeting
5
Total Number Of Directors As On Date Of The Meeting
10
Entry MeetingBOD2
Dates Of Meeting If Any In The Relevant Quarter
28-Jan-2026
Maximum Gap Between Any Two Consecutive Meetings
83
Number Of Directors Present In Meeting Of Board Of Directors
10
Number Of Independent Directors Attending The Meeting
5
Total Number Of Directors As On Date Of The Meeting
10
Entry MeetingComit1
Dates Of Meeting Of The Committee In The Previous Quarter
05-Nov-2025
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
3
Number Of Independent Director Attending Meeting Of Committee
3
Number Of Member Attending Meeting Of Committee
0
Total Number Of Directors As On Date Of The Meeting
3
Entry MeetingComit2
Dates Of Meeting Of The Committee In The Relevant Quarter
28-Jan-2026
Maximum Gap Between Any Two Consecutive Meetings
83
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
3
Number Of Independent Director Attending Meeting Of Committee
3
Number Of Member Attending Meeting Of Committee
0
Total Number Of Directors As On Date Of The Meeting
3
Entry MeetingComit3
Dates Of Meeting Of The Committee In The Relevant Quarter
16-Mar-2026
Maximum Gap Between Any Two Consecutive Meetings
46
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
3
Number Of Independent Director Attending Meeting Of Committee
3
Number Of Member Attending Meeting Of Committee
0
Total Number Of Directors As On Date Of The Meeting
3
Entry MeetingComit4
Dates Of Meeting Of The Committee In The Previous Quarter
05-Nov-2025
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
4
Number Of Independent Director Attending Meeting Of Committee
3
Number Of Member Attending Meeting Of Committee
0
Total Number Of Directors As On Date Of The Meeting
4
Entry MeetingComit5
Dates Of Meeting Of The Committee In The Relevant Quarter
28-Jan-2026
Maximum Gap Between Any Two Consecutive Meetings
83
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
4
Number Of Independent Director Attending Meeting Of Committee
3
Number Of Member Attending Meeting Of Committee
0
Total Number Of Directors As On Date Of The Meeting
4
Entry MeetingComit6
Dates Of Meeting Of The Committee In The Relevant Quarter
16-Mar-2026
Maximum Gap Between Any Two Consecutive Meetings
46
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
3
Number Of Independent Director Attending Meeting Of Committee
1
Number Of Member Attending Meeting Of Committee
0
Total Number Of Directors As On Date Of The Meeting
3
Entry MeetingComit7
Dates Of Meeting Of The Committee In The Previous Quarter
01-Oct-2025
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
5
Number Of Independent Director Attending Meeting Of Committee
3
Number Of Member Attending Meeting Of Committee
0
Total Number Of Directors As On Date Of The Meeting
5
Entry MeetingComit8
Dates Of Meeting Of The Committee In The Relevant Quarter
16-Mar-2026
Maximum Gap Between Any Two Consecutive Meetings
165
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
5
Number Of Independent Director Attending Meeting Of Committee
4
Number Of Member Attending Meeting Of Committee
0
Total Number Of Directors As On Date Of The Meeting
6
Entry MainD
Contact Information Of The Designated Officials Of The Listed Entity Who Are Responsible For Assisting And Handling Investor Grievances
Yes
Disclosure Web Link Of Company At Which Contact Information Of The Designated Officials Of The Listed Entity Who Are Responsible For Assisting And Handling Investor Grievances Is Placed
https://www.piramalpharma.com/investor-contacts
Disclosure Web Link Of Company At Which Email Address For Grievance Redressal And Other Relevant Details Is Placed
https://www.piramalpharma.com/investor-contacts
Email Address For Grievance Redressal And Other Relevant Details
Yes
No Of Investor Complaints Disposed Off During The Period
5
No Of Investor Complaints During The Period
2
No Of Investor Complaints Received During The Period
7
Whether Part B Of Annexure I Of The SEBI Circular Dated31December2024Related To Investor Grievance Redressal Report Is Applicable To The Entity
Yes
Entry MainI
No Of Investor Complaints
2
Entry PY_I
No Of Investor Complaints
0
Entry D_AcquisitionShares1
Percentage Of Shares Or Voting Rights Acquired During The Quarter
-0.0273
Entry I_AcquisitionShares_PY1
Percentage Of Aggregate Holding Of Shares Or Voting Rights
0.1576
Entry I_AcquisitionShares1
Date Of Acquisition
24-Mar-2026
Name Of The Unlisted Company In Which Shares Or Voting Rights Have Been Acquired
Clean Max Aero Private Limited
Percentage Of Aggregate Holding Of Shares Or Voting Rights
0.1303
Entry MainD
Any Other Information For Disclosure Of Acquisition Of Shares Or Voting Rights In Unlisted Companies Explanatory Text Block
During the quarter, the Company made a second tranche of equity investment within the overall limit of up to Rs. 2.16 Crores via Private Placement in Clean Max Aero Private Limited, a Special Purpose Vehicle (SPV) of Clean Max Enviro Energy Solutions Private Limited. Consequent to the aforesaid equity investment, the shareholding of the Company stands revised from 15.76% to 13.03% in Clean Max Aero Private Limited
Composition Of Board Of Directors Of Unlisted Material Subsidiary
Yes
Whether Part C Of Annexure I Of The SEBI Circular Dated31December2024Related To Disclosure Of Acquisition Of Shares Or Voting Rights In Unlisted Companies Is Applicable To The Entity
Yes
Reason For Part E Of Annexure I Of The SEBI Circular Dated31December2024Related To Disclosure Of Updates To Ongoing Tax Litigations Or Disputes Is Not Applicable To The Entity
There are no updates on Ongoing Tax Litigation or Disputes during the quarter in terms of sub-para 8 of para B of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Whether Part E Of Annexure I Of The SEBI Circular Dated31December2024Related To Disclosure Of Updates To Ongoing Tax Litigations Or Disputes Is Applicable To The Entity
No
Entry I_ImpositionOfFineOrPenalty1
Authority
City of Bethlehem (Bethlehem Wastewater Treatment Plant)
Date Of Receipt Of Direction Or Order Including Any Ad Interim Or Interim Orders Or Any Other Communication From The Authority
23-Jan-2026
Financial / Operational Impact
There is no impact on financial, operation or other activities of the Company, other than penalty amount.
Nature And Details Of The Action Taken Or Order Passed
A Notice of Violation was issued alongwith a civil penalty of $200  to Piramal Critical Care Inc, wholly owned subsidiary of the Company for an alleged exceedance of diethylamine in our waste water discharge to the city of  Bethlehem
Violation Details
The authority alleged exceedance of diethylamine at the Bethlehem site via Notice of Violation. Piramal Critical Care Inc (PCCI) responded to the Notice of Violation and Order of Compliance dated January 23, 2026.The root cause was an external lab error. The site does not have DEA in the wastewater discharge. The PCC Bethlehem (PCC BET) will utilize a different qualified and certified external laboratory to analyze shadow samples in parallel with regulatory testing. This approach will enable the site to promptly challenge and contest any future false or inaccurate results generated by the laboratory selected by the authorities.
Entry MainD
Whether Part D Of Annexure I Of The SEBI Circular Dated31December2024Related To Disclosure Of Imposition Of Fine Or Penalty Is Applicable To The Entity
Yes